To rule out off-target effects of a particular ATR inhibitor, we confirmed the effects of ATR inhibition using a different ATR inhibitor in our lung cancer models for clonogenic cell survival and RAD51 foci formation. This evidence concerns the gene ATR and lung carcinoma.